Drugs / AD-3031
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07490327 Comparator | Apr → Sep 2026 overdue | androgenetic alopecia | Moogene Medi Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD-3031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07490327 ↗ |
| Route | Oral | “Oral AD-3031 administered according to the study protocol.” NCT07490327 ↗ |